NR (Nicotinamide Riboside)

Also known as: Niagen, nicotinamide riboside, NR

Grade B — Moderate EvidenceNAD+ precursorlongevity

Recommended Dosage

3001000 mg

Morning with food

NAD+ precursor with strong human RCT evidence for NAD+ elevation. Unique cardiovascular benefits: reduced arterial stiffness and blood pressure.

Last reviewed: 2026-03-09

Evidence Rating: Grade B — Moderate Evidence

Some RCTs with positive results, or strong observational evidence. More research may refine our understanding.

Interaction Warnings

ChemotherapyModerate

NAD+ boosting may theoretically support cancer cell survival; consult oncologist

⚠️ Important Notes

  • Niagen (Chromadex) is most clinically studied form
  • Headache, flushing, nausea uncommon at higher doses
  • Often combined with TMG/resveratrol

Clinical Evidence (3 studies)

NR robustly elevated human blood NAD+

Trammell SAJ et al. (2016) — Nat Commun

First human pharmacokinetics: dose-dependent NAD+ elevation

View on PubMed

NR reduced aortic stiffness and blood pressure

Martens CR et al. (2018) — Nat Commun

1g/day for 6 weeks reduced aortic stiffness and BP in middle-aged adults

View on PubMed

NR raised NAD+ in skeletal muscle

Dollerup OL et al. (2018) — Nat Commun

1g/day for 12 weeks raised NAD+ in skeletal muscle; no adverse effects

View on PubMed

Related Supplements

🧪 Get Your Personalized Stack

See how NR (Nicotinamide Riboside) fits with your goals and current supplements — AI-powered, evidence-graded recommendations.

⚕️ Important Disclaimer

This information is for educational purposes only. It is not medical advice. Always consult a healthcare provider before starting any supplement regimen, especially if you take medications or have health conditions.

Evidence Stack does not sell supplements and has no affiliate relationships with supplement manufacturers.